Work

A Phase I/II Trial on Melphalan, Prednisone, Thalidomide and Defribotide Combination in Relapsed/Refractory Multiple Myeloma Patients.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.2715.2715

Authors: Antonio Palumbo, Alessandra Larocca, Cecilia Rus, Francesca Gay, Davide Rossi, Patrizia Pregno, Patrizia Falco, Ilaria Avonto, Valeria Magarotto, Federica Cavallo, Massimo Iacobelli, Gianluca Gaidano, Constantine Mitsiades, Paul G. Richardson, Kenneth C. Anderson, Mario Boccadoro

Institutions: Azienda Ospedaliero Universitaria San Giovanni Battista, University of Turin, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2552535428

FWCI: 0.204

Cites:

Cited by: 1

Related to: 10